A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents

Brian Finan(Helmholtz Zentrum München), Bin Yang(Indiana University Bloomington), Nickki Ottaway(University of Cincinnati Medical Center), David L. Smiley(Indiana University Bloomington), Tao Ma(Indiana University Bloomington), Christoffer Clemmensen(Helmholtz Zentrum München), Joe Chabenne(Indiana University Bloomington), Lianshan Zhang(Acadia Pharmaceuticals (United States)), Kirk M. Habegger(University of Alabama at Birmingham), Katrin Fischer(Helmholtz Zentrum München), Jonathan E. Campbell(University of Toronto), Darleen A. Sandoval(University of Cincinnati Medical Center), Randy J. Seeley(University of Cincinnati Medical Center), Konrad Bleicher(Roche (Switzerland)), Sabine Uhles(Roche (Switzerland)), William Riboulet(Roche (Switzerland)), Jürgen Funk(Roche (Switzerland)), Cornelia Hertel(Roche (Switzerland)), Sara Belli(Roche (Switzerland)), E Seböková(Roche (Switzerland)), Karin Conde‐Knape(Roche (Switzerland)), Anish Konkar(Roche (Switzerland)), Daniel J. Drucker(University of Toronto), Vasily M. Gelfanov(Indiana University Bloomington), Paul T. Pfluger(Helmholtz Zentrum München), Timo D. Müller(Helmholtz Zentrum München), Diego Pérez–Tilve(University of Cincinnati Medical Center), Richard D. DiMarchi(Indiana University Bloomington), Matthias H. Tschöp(Helmholtz Zentrum München)
Nature Medicine
December 8, 2014
Cited by 621Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis